News

Summer is closing with an abundance of new data on SMA. Studies aimed at understanding the disease process continue to provide information on its underlying mechanisms. At the same time, careful investigations of therapeutics are highlighting the potential of these interventions and identifying critical questions for future research, as well…

Your typical SMA patient spends much of their day sitting in a wheelchair. While this may be normal for them, it can cause problems with muscle tightness and soreness during their typical day. My patient, Michael, was diagnosed with severe hip, muscle, and nerve damage in his right…

In July, the literature pertaining to spinal muscular atrophy (SMA) has focused mainly on understanding the disease. Information on treatments has been published largely in review form, while there has also been some new information on managing the disease and what having the disease means for patients.  Here is…

  While the majority of students in physical therapy learn how to transfer patients in school with many different assistance requirements, patients who suffer from spinal muscular atrophy usually present more of a challenge than many physical therapists come across in the field, especially working in an outpatient setting. Some…

Over the past couple of weeks, there have been several new publications regarding spinal muscular atrophy (SMA) treatment. There has also been continued work in the basic science that aims to provide more understanding of the disease as well as research providing information relevant for the management of SMA. …

Since our last roundup, there has been continued focus in the spinal muscular atrophy (SMA) literature how best to treat the disease. There also continues to be research geared toward understanding the biology of the disease, as well as on SMA management, what it is like to live with the…

[two_third_last] If you are working with a patient with SMA, you will most likely find that they are in their wheelchair full time. This makes sitting balance very important for many reasons. If they have good sitting balance, this will make traveling up and down ramps easier and more…

Much of the most recent research regarding spinal muscular atrophy (SMA) has focused on understanding the mechanisms mediating the disease as well as the clinical value of different pharmaceutical interventions. There have been several reviews on the latter topic, with a continuing emphasis on nusinersen, the first drug approved to…

Zolgensma, a first gene therapy for spinal muscular atrophy — and first for any chronic neurologic disease — is now an approved and potential “one-time” intravenous treatment for pre-symptomatic newborns through 2-year-olds with any type of SMA, the U.S. Food and Drug Administration (FDA) announced today, issuing an historic decision.

For a patient with SMA to be able to function with their maximal amount of independence, it is important to have as much range of motion possible. As with the majority patients with SMA, my current patient with SMA spends most of his time in his wheelchair. Therefore, he…